[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.14348/molcells.2018.2227

Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells

Fujiki, Hirota (Faculty of Medicine, Saga University)
Watanabe, Tatsuro (Faculty of Medicine, Saga University)
Sueoka, Eisaburo (Faculty of Medicine, Saga University)
Rawangkan, Anchalee (Graduate School of Science and Engineering, Saitama University)
Suganuma, Masami (Graduate School of Science and Engineering, Saitama University)

Abstract

Cancer preventive activities of green tea and its main constituent, (-)-epigallocatechin gallate (EGCG) have been extensively studied by scientists all over the world. Since 1983, we have studied the cancer chemopreventive effects of EGCG as well as green tea extract and underlying molecular mechanisms. The first part of this review summarizes groundbreaking topics with EGCG and green tea extract: 1) Delayed cancer onset as revealed by a 10-year prospective cohort study, 2) Prevention of colorectal adenoma recurrence by a double-blind randomized clinical phase II trial, 3) Inhibition of metastasis of B16 melanoma cells to the lungs of mice, 4) Increase in the average value of Young's moduli, i.e., cell stiffness, for human lung cancer cell lines and inhibition of cell motility and 5) Synergistic enhancement of anticancer activity against human cancer cell lines with the combination of EGCG and anticancer compounds. In the second part, we became interested in cancer stem cells (CSCs). 1) Cancer stem cells in mouse skin carcinogenesis by way of introduction, after which we discuss two subjects from our review on human CSCs reported by other investigators gathered from a search of PubMed, 2) Expression of stemness markers of human CSCs compared with their parental cells, and 3) EGCG decreases or increases the expression of mRNA and protein in human CSCs. On this point, EGCG inhibited self-renewal and expression of pluripotency-maintaining transcription factors in human CSCs. Human CSCs are thus a target for cancer prevention and treatment with EGCG and green tea catechins.

Keywords

AFM; Nanog; Oct4; Sox2; stemness;

Citations & Related Records

Reference

1	Suganuma, M., Okabe, S., Kai, Y., Sueoka, N., Sueoka, E., and Fujiki, H. (1999). Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 59, 44-47.
2	Suganuma, M., Kurusu, M., Suzuki, K., Tasaki, E., and Fujiki, H. (2006). Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int. J. Cancer 119, 33-40. DOI
3	Suganuma, M., Saha, A., and Fujiki, H. (2011). New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci. 102, 317-323. DOI
4	Suganuma, M., Takahashi, A., Watanabe, T., Iida, K., Matsuzaki, T., Yoshikawa, H.Y., and Fujiki, H. (2016). Biophysical approach to mechanisms of cancer prevention and treatment with green tea catechins. Molecules 21, pii: E1566.
5	Pan, X., Zhao, B., Song, Z., Han, S., and Wang, M. (2016). Estrogen receptor- ${\alpha}$ 36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells. J. Pharmacol. Sci. 130, 85-93. DOI
6	Sarkar, A., and Hochedlinger K (2013). The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 12, 15-30. DOI
7	Shimizu, M., Fukutomi, Y., Ninomiya, M., Nagura, K., Kato, T., Araki, H., Suganuma, M., Fujiki, H., and Moriwaki, H. (2008). Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 17, 3020-3025. DOI
8	Shin, C.M., Lee, D.H., Seo, A.Y., Lee, H.J., Kim, S.B., Son, W.C., Kim, Y.K., Lee, S.j., Park, S.H., Kim, N., et al. (2017). Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial. Clin. Nutr. Pii:S0261-5614(17)30038-9.
9	Slaga, T.J., and Klein-Szanto, A.J. (1983). Initiation-promotion versus complete skin carcinogenesis in mice: importance of dark basal keratinocytes (stem cells). Cancer Invest. 1, 425-436. DOI
10	Sporn, M.B., Dunlop, N.M., Newton, D.L., and Smith, J.M. (1976). Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 35, 1332-1338.
11	Yoshizawa, S., Horiuchi, T., Suganuma, M., Nishiwaki, S., Yatsunami, J., Okabe, S., Okuda, T., Muto, Y., Frenkel, K., Troll, W., et al. (1992). Penta-O-galloyl- ${\beta}$ -D-glucose and (-)-epigallocatechin gallate cancer preventive agents. ACS Symposium Series. 501, 316-325.
12	Yamane, T., Takahashi, T., Kuwata, K., Oya, K., Inagake, M, Kitao, Y., Suganuma, M, and Fujiki, H. (1995). Inhibition of N-methyl-N’-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55, 2081-2084.
13	Yang, C.S., Wang, X., Lu, G., and Picinich, S.C. (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 9, 429-439. DOI
14	Yoshizawa, S., Horiuchi, T., Fujiki, H., Yoshida, T., Okuda, T., and Sugimura, T. (1987). Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea. Phytother. Res. 1, 44-47. DOI
15	Zhang, X.T., Kang, L.G., Ding, L., Vranic, S., Gatalica, Z., and Wang, Z.T. (2011). A positive feedback loop of ER- ${\alpha}$ 36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene 30, 770-780. DOI
16	Zhu, J., Jiang, Y., Yang, X., Wang, S., Xie, C., Li ,X., Li, Y., Chen, Y., Wang, X., Meng, Y., et al. (2017). Wnt/ ${\beta}$ -catenin pathway mediates (-)-epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells. Biochemical Biophys. Res. Commun. 482, 15-21. DOI
17	Surh, Y.J. (2003). Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3, 768-780. DOI
18	Suganuma, M., Okabe, S., Oniyama, M., Tada, Y., Ito, H., and Fujiki, H. (1998). Wide distribution of [ $^{3}H$ ](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19,1771-1776. DOI
19	Stingl, J.C., Ettrich, T., Muche, R., Wiedom, M., Brockmoller, J., Seeginger, A., and Seufferlein, T. (2011). Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. B.M.C. Cancer 11, 360. DOI
20	Suganuma, M., Fujiki, H., Suguri, H., Yoshizawa, S., Hirota, M., Nakayasu, M, Ojika, M., Wakamatsu, K., Yamada, K., and Sugimura, T. (1988). Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA 85, 1768-1771. DOI
21	Imai, K., Suga, K., and Nakachi, K. (1997). Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26, 769-775. DOI
22	Takahashi, A., Watanabe, T., Mondal, A., Suzuki, K., Kurusu-Kanno, M., Li, Z., Yamazaki, T., Fujiki, H., and Suganuma, M. (2014). Mechanism-based inhibition of cancer metastasis with (-)-epigallocatechin gallate. Biochem. Biophys. Res. Commun. 443, 1-6. DOI
23	Okabe, S., Suganuma, M., Hayashi, M., Sueoka, E., Komori, A., and Fujiki, H. (1997). Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res. 88, 639-643. DOI
24	Okabe, S., Ochiai, Y., Aida, M., Park, K., Kim, S.J., Nomura, T., Suganuma, M., and Fujiki, H. (1999). Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn. J. Cancer Res. 90, 733-739. DOI
25	Kashyap, V., Rezende, N.C., Scotland, K.B., Shaffer, S.M., Persson, J.L., Gudas, L.J., and Mongan, N.P. (2009). Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 18, 1093-1108. DOI
26	Fujiki, H., Sueoka, E., Rawangkan, A., and Suganuma, M. (2017). Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. J. Cancer Res. Clin. Oncol. DOI: 10.1007/s00432-017-2515-2 DOI
27	Fujita, Y., Yamane, T., Tanaka, M., Kuwata, K., Okuzumi, J., Takahashi, T., Fujiki, H., and Okuda, Y. (1989). Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N'-nitro-Nnitrosoguanidine in mouse duodenum. Jpn. J. Cancer Res. 80, 503-505. DOI
28	Gerdes, M.J., and Yuspa, S.H. (2005). The contribution of epidermal stem cells to skin cancer. Stem Cell Rev. 1, 225-231. DOI
29	Gupta, S., Hastak, K., Ahmad, N., Lewin, J.S., and Mukhtar, H. (2001). Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 98, 10350-10355. DOI
30	Hoensch, H., Groh, B., Edler, L., and Kirch, W. (2008). Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence. World J. Gastroenterol. 14, 2187-2193. DOI
31	Inoue, M., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Hirose, K., Hamajima, N., and Tominaga, S. (2001). Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiological Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 167, 175-182. DOI
32	Jones, P.H., and Watt, F.M. (1993). Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73, 713-724. DOI
33	Morris, R.J., Tryson, K.A., and Wu, K.Q. (2000). Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis or infundibulum as well as in the hair follicles. Cancer Res. 60, 226-229.
34	Komori, A., Yatsunami, J., Okabe, S., Abe, S., Hara, K., Suganuma, M., Kim, S.J., and Fujiki, H. (1993). Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 23, 186-190
35	Lin, C.H., Shen, Y.A., Hung, P.H., Yu, Y.B., and Chen, Y.J. (2012). Epigallocatechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines. BMC Complement Alern. Med. 12, 201. DOI
36	Mineva, N.D., Paulson, K.E., Naber, S.P., Yee, A.S., and Sonenshein, G.E. (2013). Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells. PLoS One 8, e73464. DOI
37	Nakachi, K., Suemasu, K., Suga, K., Takeo, T., Imai, K., and Higashi, Y. (1998). Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89, 254-261. DOI
38	Nakachi, K., Matsuyama, S., Miyake, S., Suganuma, M., and Imai, K. (2000). Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactor 13, 49-54. DOI
39	Ogunleye, A.A., Xue, F., and Michels, K.B. (2010). Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 119, 477-484. DOI
40	Tang, S.N., Fu, J., Nall, D., Rodova, M., Shankar, S., and Srivastava, R.K. (2012). Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int. J. Cancer 131, 30-40. DOI
41	Taniguchi, S., Fujiki, H., Kobayashi, H., Go, H., Miyado, K., Sadano, H., Shimokawa, R. (1992). Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett. 65, 51-54. DOI
42	Toden, S., Tran, H.M., Tovar-Camargo, O.A., Okugawa, Y., and Goel, A. (2016). Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Oncotarget. 7, 16158-16170.
43	Trempus, C.S., Morris, R.J., Ehinger, M., Elmore, A., Bortner, C.D., Ito, M., Cotsarelis, G., Nijhof, J.G.W., Peckham, J., Flagler, N., et al. (2007). CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res. 67, 4173-4181. DOI
44	Tsao, A.S., Liu, D., Martin, J., Tang, X.M., Lee, J.J., El-Naggar, A.K., Wistuba, I., Culotta, K.S., Mao, L., Gillenwater, A., et al. (2009). Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev. Res. 2, 931-941. DOI
45	Watanabe, T., Kuramochi, H., Takahashi, A., Imai, K., Katsuta, N., Nakayama, T., Fujiki, H., and Suganuma, M. (2012). Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells. J. Cancer Res. Clin. Oncol. 138, 859-866. DOI
46	Conney, A.H., Wang, Z.Y., Huang, M.T., Ho, C.T., and Yang, C.S. (1992). Inhibitory effect of oral administration of green tea on tumorigenesis by ultraviolet light, 12-O-tetradecanoylphorobol-13-acetate and N-nitrosodiethylamine in mice. In Cancer Chemoprevention, L.W. Wattenberg, M. Lipkin, C.W. Boone, and G.J. Kelloff, eds. (Florida: CRC Press), pp. 361-373.
47	Beck, B., Driessens, G., Goossens, S., Youssef, K.K., Kuchnio, A., Caauwe, A., Sotiropoulou, P.A., Loges, S., Lapouge, G., Candi, A., et al. (2011). A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478, 399-403. DOI
48	Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., and Corti, A. (2006). Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a oneyear proof-of-principle study. Cancer Res. 66, 1234-1240. DOI
49	Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., et al. (2014). SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511, 246-250. DOI
50	Boutwell, R.K. (1977). The role of the induction of ornithine decarboxylase in tumor promotion. In Origins of Human Cancer, H.H. Hiatt, J. D. Watson and J. A. Winsten, eds. (New York, Cold Spring Harbor Laboratory), pp. 773-783.
51	Cross, S.E., Jin, Y.S., Rao, J.K., and Gimzewski, J.K. (2007). Nanomechanical analysis of cells from cancer patients. Nat. Nanotechnol. 2, 780-783. DOI
52	Cross, S.E., Jin, Y.S., Lu, Q.Y., Rao, J.Y., and Gimzewski, J.K. (2011). Green tea extract selectively targets nanomechanics of liver metastatic cancer cells. Nanotechnology 22, 215101. DOI
53	Editor (1987). Green tea cuts cancerous growths. New Scientist. 116, 1586, 32.
54	Affara, N.I., Trempus, C.S., Schanbacher, B.L., Pei, P., Mallery, S.R., Bauer, J.A., and Robertson, F.M. (2006). Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multistage mouse skin carcinogenesis. Anticancer Res. 26, 2805-2820.
55	Fujiki, H. (2017). Green tea cancer prevention. In Encylopedia of Cancer, M. Schwab ed. (Berlin Heidelberg: Springer-Verlag), pp. 1960-1965.
56	Fujiki, H., and Okuda T. (1992). (-)-Epigallocatechin gallate. Drugs Future 17, 462-464. DOI
57	Fujiki, H., Suganuma, M., Imai, K., and Nakachi, K. (2002). Green tea: cancer preventive beverage and/or drug. Cancer Lett. 188, 9-13. DOI
58	Fujiki, H., and Suganuma, M. (1993). Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res. 61, 143-194.
59	Fujiki, H., and Suganuma, M. (2002). Green tea and cancer prevention. Proc. Jpn. Acad. 78(B), 263-270. DOI
60	Fujiki, H., Suganuma, M., Okabe, S., Sueoka, E., Sueoka, N., Fujimoto, N., Goto, Y., Matsuyama, S., Imai, K., and Nakachi, K. (2001). Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res. 480-481, 299-304. DOI
61	Fujiki, H., Imai, K., Nakachi, K., Shimizu, M., Moriwaki, H., and Suganuma, M. (2012). Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J. Cancer Res. Clin. Oncol. 138, 1259-1270. DOI
62	Fujiki, H., Sueoka, E., and Suganuma, M. (2013). Tumor promoters: from chemicals to inflammatory proteins. J. Cancer Res. Clin. Oncol. 139, 1603-1614. DOI
63	Stearns, M.E., and Wang, M. (2011). Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl. Oncol. 4, 147-156. DOI
64	Fujiki, H., Sueoka, E., Watanabe, T., and Suganuma, M. (2015a). Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds. J. Cancer Res. Clin. Oncol. 141, 1511-1522. DOI
65	Fujiki, H., Sueoka, E., Watanabe, T., and Suganuma, M. (2015b). Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. J. Cancer Prev. 20, 1-4. DOI

Reference

8	(2018) Molecules Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth / 23 (8) , 2071
1549-7852	(2019) Critical Reviews in Food Science and Nutrition Prevention of breast cancer by dietary polyphenols—role of cancer stem cells / (1549-7852) , 1
1	(2018) Journal of experimental & clinical cancer research Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects / 37 (1) , 261
None	(2018) Frontiers in oncology Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth / 8 (None) , 356
3	(2018) Medicines : open access journal Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer / 5 (3) , 87
22	(2018) Journal of medicinal chemistry Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics / 61 (22) , 9791
12	(2018) Nutrients Green Tea Consumption and Risk of Breast Cancer and Recurrence—A Systematic Review and Meta-Analysis of Observational Studies / 10 (12) , 1886
6	(2018) Neurochemical research Regulation of Neprilysin Activity and Cognitive Functions in Rats After Prenatal Hypoxia / 44 (6) , 1387
None	(2019) Scientific reports Multilevel structure-activity profiling reveals multiple green tea compound families that each modulate ubiquitin-activating enzyme and ubiquitination by a distinct mechanism / 9 (None) , 12801
5	(2018) Molecules Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer / 24 (5) , 954
22	(2018) Oncotarget Prevention of therapy-related malignances in cancer survivors / 10 (22) , 2114
9	(2018) Molecules Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors / 24 (9) , 1726
None	(2018) SAGE Open medicine A review of nutrition and dietary interventions in oncology / 8 (None) , 2050312120926877
None	(2020) Journal of nanomaterials The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment / 2020 (None) , 1
None	(2018) Frontiers in immunology Impact of Gallic Acid on Gut Health: Focus on the Gut Microbiome, Immune Response, and Mechanisms of Action / 11 (None) , 580208
2	(2018) Journal of chemotherapy Recent advances in natural therapeutic approaches for the treatment of cancer / 32 (2) , 53
3	(2018) Nutrition and cancer Antimetastatic Properties of Tea Polyphenols / 72 (3) , 365
8	(2018) Molecules Coumaroyl Flavonol Glycosides and More in Marketed Green Teas: An Intrinsic Value beyond Much-Lauded Catechins / 25 (8) , 1765
8	(2020) Critical reviews in food science and nutrition Nutrigenomics: Epigenetics and cancer prevention: A comprehensive review / 60 (8) , 1375
5	(2018) Antioxidants Bioavailability of Epigallocatechin Gallate Administered with Different Nutritional Strategies in Healthy Volunteers / 9 (5) , 440
10	(2020) Critical reviews in food science and nutrition Effects and mechanisms of tea for the prevention and management of cancers: An updated review / 60 (10) , 1693
None	(2020) BMC gastroenterology Effectiveness of concomitant use of green tea and polyethylene glycol in bowel preparation for colonoscopy: a randomized controlled study / 20 (None) , 150
6	(2020) Environmental monitoring and assessment Effective disposal of methylene blue using green immobilized silver nanoparticles on graphene oxide and reduced graphene oxide sheets through one-pot synthesis / 192 (6) , 355
8	(2018) Cancers MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors / 12 (8) , 2111
10	(2018) Antioxidants An Update on the Role of Dietary Phytochemicals in Human Skin Cancer: New Insights into Molecular Mechanisms / 9 (10) , 916
4	(2020) Journal of dentistry Camellia Sinensis Mouthwashes in Oral Care: a Systematic Review / 21 (4) , 249
1	(2018) Molecules Health Benefits and Chemical Composition of Matcha Green Tea: A Review / 26 (1) , 85
5	(2018) International journal of molecular sciences Epigallocatechin-3-gallate Can Prevent Type 2 Human Papillomavirus E7 from Suppressing Interferon-Stimulated Genes / 22 (5) , 2418
16	(2018) Journal of cellular and molecular medicine EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells / 25 (16) , 7913
18	(2018) International journal of molecular sciences Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer / 22 (18) , 9807